Product categories

Nuclear Medicine

IODOSOL 123I (R&D)

Name:
Iodosol 123I (R&D)

Active Principle:
Sodium Iodide (123I)

Therapeutic Action:
Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.

IODOSOL 123I (R&D)

Línea

Nuclear Medicine

Sublínea

SPECT Radiopharmaceuticals

IODOSOL 123I (R&D)

IODOSOL 123I (R&D)

Línea

Nuclear Medicine

Sublínea

SPECT Radiopharmaceuticals

IODOSOL 123I (R&D)

Nuclear Medicine

IODOSOL 123I (R&D)

Name:
Iodosol 123I (R&D)

Active Principle:
Sodium Iodide (123I)

Therapeutic Action:
Sodium iodide (123I) solution is indicated as a diagnostic agent to evaluate thyroid function and/or morphology by scintigraphy and radioactive iodine uptake test.

Product categories

RELATED PRODUCTS

  • FDG

    FDG
    It is indicated for the measurement of glucose metabolism, the diagnosis of primary, recurrent or metastatic disease of various tumors and for the study of cardiomyopathies, osteoarthropathie...
    Ver más

  • DOPA

    DOPA
    In Neurology it is indicated to evaluate the state of the striatum in patients with altered motor signs and to detect the loss of functional dopaminergic nerve endings. They allow to differentiate Idiopathic...
    Ver más

  • TECHNETIUM GENERATOR

    TECHNETIUM GENERATOR
    It is indicated for obtaining a solution of Sodium Pertechnetate (Tc99m) ...
    Ver más

  • CAPSUBAC

    CAPSUBAC
    It is indicated for the treatment of hyperthyroidism and in special cases of thyroid carcinoma. This medicine is for therapeutic use in: - Graves' disease, single or multiple diffuse toxic multinodular...
    Ver más

  • LINFOFAST

    LINFOFAST
    It is indicated for scintigraphic visualization of lymphatic vessels and lymph node stations by means of static or dynamic lymphoscintigraphy or radioisotopic lymphography. The static morphological...
    Ver más

  • MIBG 131 WITHOUT CARRIER (R&D)

    MIBG 131 WITHOUT CARRIER (R&D)
    It is a radioactive therapeutic agent indicated for ...
    Ver más

  • 131I MIBG BACON (R&D)

    131I MIBG BACON (R&D)
    It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas...
    Ver más

  • 123I MIBG BACON (R&D)

    123I MIBG BACON (R&D)
    It is indicated for: Oncology: a) Scintigraphic localization of tumors originating in tissues that derive embryologically from the neural crest...
    Ver más